SeaStar Medical Holding (ICU) 10-Q2024 Q3 Quarterly report

Filed: 13 Nov 24, 5:18pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: aging, al, assemble, assembled, ATM, begun, build, captioned, cartridge, catastrophic, cGMP, channel, confidential, constructed, contamination, coupled, destination, directly, educational, efficient, environmental, experience, explained, facility, fall, fee, FOB, formation, gave, global, Good, independent, insourcing, interrupted, introduce, inventory, kit, kitted, kitting, main, maintenance, manufacture, manufacturing, method, monitor, multiple, opening, oriented, partner, Practice, procure, promulgated, quality, ratification, recruiting, relationship, resell, resold, returned, schedule, short, substantive, supplier, tradename, tubing, underway, uninterrupted, unique, usage, vi, Wainwright

Removed: assist, Breakthrough, cardiorenal, carried, Designation, Division, extension, hiring, implantation, Innovative, payroll, primary, repayment, ventricular, worsening

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ICU similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Eric Schlorff, Chief Executive Officer of SeaStar Medical Holding Corporation (the “Company”), certify that:

1. the Quarterly Report on Form 10-Q of the Company for the three and nine months ended September 30, 2024 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2024



/s/ Eric Schlorff
Eric Schlorff
Chief Executive Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.